These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10739543)

  • 1. Highly abnormal maternal inhibin and beta-human chorionic gonadotropin levels along with severe HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome at 17 weeks' gestation with triploidy.
    Craig K; Pinette MG; Blackstone J; Chard R; Cartin A
    Am J Obstet Gynecol; 2000 Mar; 182(3):737-9. PubMed ID: 10739543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.
    Wenstrom KD; Owen J; Chu DC; Boots L
    Am J Obstet Gynecol; 1997 Nov; 177(5):987-91. PubMed ID: 9396880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
    Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia.
    Ashour AM; Lieberman ES; Haug LE; Repke JT
    Am J Obstet Gynecol; 1997 Feb; 176(2):438-42. PubMed ID: 9065195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester.
    Spencer K; Liao AW; Ong CY; Geerts L; Nicolaides KH
    Prenat Diagn; 2001 Jun; 21(6):441-4. PubMed ID: 11438945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
    Wenstrom KD; Owen J; Chu Dc; Boots L
    Am J Obstet Gynecol; 1999 Oct; 181(4):887-92. PubMed ID: 10521748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A.
    Fitzgerald B; Levytska K; Kingdom J; Walker M; Baczyk D; Keating S
    Placenta; 2011 Apr; 32(4):339-45. PubMed ID: 21388678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperreactio luteinalis could be a risk factor for development of HELLP syndrome: case report.
    Grgic O; Radakovic B; Barisic D
    Fertil Steril; 2008 Nov; 90(5):2008.e13-6. PubMed ID: 18829007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M; Nørgaard-Pedersen B
    Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum activin A and inhibin A in trisomy 18 pregnancies at 10-14 weeks.
    Spencer K; Liao AW; Ong CY; Flack NJ; Nicolaides KH
    Prenat Diagn; 2001 Jul; 21(7):571-4. PubMed ID: 11494294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of partial mole and atypical type I triploidy associated with severe HELLP syndrome at 18 weeks' gestation.
    Stefos T; Plachouras N; Mari G; Cosmi E; Lolis D
    Ultrasound Obstet Gynecol; 2002 Oct; 20(4):403-4. PubMed ID: 12383328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
    Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
    Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies.
    Aitken DA; Ireland M; Berry E; Crossley JA; Macri JN; Burn J; Connor JM
    Prenat Diagn; 1999 Aug; 19(8):706-10. PubMed ID: 10451512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester.
    Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1997 Jul; 17(7):601-6. PubMed ID: 9249859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-trimester dimeric inhibin-A in Down's syndrome screening.
    Spencer K; Wallace EM; Ritoe S
    Prenat Diagn; 1996 Dec; 16(12):1101-10. PubMed ID: 8994245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of triploidy at 11-14 weeks' gestation: a cohort study of 198 000 pregnant women.
    Engelbrechtsen L; Brøndum-Nielsen K; Ekelund C; Tabor A; Skibsted L;
    Ultrasound Obstet Gynecol; 2013 Nov; 42(5):530-5. PubMed ID: 23494847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A can detect triploidy and determine the parental origin.
    Yaron Y; Ochshorn Y; Tsabari S; Shira AB
    Prenat Diagn; 2004 Jun; 24(6):445-50. PubMed ID: 15229844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.